E Vieta

Author PubWeight™ 104.99‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The bipolar-borderline personality disorders connection in major depressive patients. Acta Psychiatr Scand 2013 3.12
2 Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome. Bipolar Disord 2004 2.21
3 Ethical questions in human clinical psychopharmacology: should the focus be on placebo administration? J Psychopharmacol 2008 2.07
4 Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial. Br J Psychiatry 2009 1.97
5 Functional outcome in bipolar disorder: the role of clinical and cognitive factors. Bipolar Disord 2007 1.65
6 Risk factors for suicide in schizophrenia: systematic review and clinical recommendations. Acta Psychiatr Scand 2014 1.54
7 Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand 2013 1.52
8 Predominant recurrence polarity among 928 adult international bipolar I disorder patients. Acta Psychiatr Scand 2011 1.52
9 "Is bipolar disorder an endocrine condition?" Glucose abnormalities in bipolar disorder. Acta Psychiatr Scand 2013 1.50
10 Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina. Clin Ther 2000 1.46
11 Neuropsychological and psychiatric complications in endoscopic third ventriculostomy: a clinical case report. J Neurol Neurosurg Psychiatry 2001 1.42
12 Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom 2009 1.37
13 Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 2000 1.35
14 Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol Med 2012 1.25
15 Identifying and improving non-adherence in bipolar disorders. Bipolar Disord 2005 1.24
16 Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am 2005 1.21
17 Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci 2011 1.20
18 Clinical and neurocognitive predictors of functional outcome in bipolar euthymic patients: a long-term, follow-up study. J Affect Disord 2009 1.17
19 Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord 2006 1.15
20 Cognitive dysfunctions in bipolar disorder: evidence of neuropsychological disturbances. Psychother Psychosom 2000 1.11
21 Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome. Psychother Psychosom 2001 1.10
22 Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity. Eur Arch Psychiatry Clin Neurosci 2013 1.08
23 Treatment guidelines for bipolar disorder: a critical review. J Affect Disord 2005 1.08
24 Physical and psychosocial functioning of 117 survivors of bone marrow transplantation. Bone Marrow Transplant 1996 1.05
25 Impact of a psychoeducational family intervention on caregivers of stabilized bipolar patients. Psychother Psychosom 2004 1.04
26 Stabilizing the stabilizer: group psychoeducation enhances the stability of serum lithium levels. Bipolar Disord 2005 1.03
27 Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force Report. Acta Psychiatr Scand 2014 0.99
28 Predominant polarity in bipolar disorder: diagnostic implications. J Affect Disord 2007 0.99
29 Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom 2005 0.99
30 Clinical implications of predominant polarity and the polarity index in bipolar disorder: a naturalistic study. Acta Psychiatr Scand 2013 0.98
31 Weight gain in bipolar disorder: pharmacological treatment as a contributing factor. Acta Psychiatr Scand 2008 0.97
32 Treatment-resistant bipolar depression: towards a new definition. Acta Psychiatr Scand 2009 0.97
33 Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 2007 0.96
34 Variability in the serotonin transporter gene and increased risk for major depression with melancholia. Hum Genet 1998 0.94
35 Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study. Acta Psychiatr Scand 2006 0.94
36 The road to DSM-V. Bipolar disorder episode and course specifiers. Psychopathology 2009 0.93
37 Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis. J Affect Disord 2009 0.93
38 Onset-age of bipolar disorders at six international sites. J Affect Disord 2009 0.92
39 Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe. J Psychiatr Res 2008 0.92
40 Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview. Acta Psychiatr Scand 2012 0.91
41 Functional impairment in patients with remitted bipolar disorder. Psychother Psychosom 2008 0.91
42 One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. Acta Psychiatr Scand 2012 0.91
43 Are bipolar disorders underdiagnosed in patients with depressive episodes? Results of the multicenter BRIDGE screening study in Germany. J Affect Disord 2012 0.90
44 Impulsivity and functional impairment in bipolar disorder. J Affect Disord 2011 0.89
45 Psychoeducation for bipolar II disorder: an exploratory, 5-year outcome subanalysis. J Affect Disord 2008 0.89
46 Bipolar disorder, schizoaffective disorder and schizophrenia: epidemiologic, clinical and prognostic differences. Eur Psychiatry 2001 0.89
47 Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability. J Affect Disord 2011 0.87
48 Functional impairment in bipolar II disorder: is it as disabling as bipolar I? J Affect Disord 2010 0.87
49 Are bipolar II patients cognitively impaired? A systematic review. Psychol Med 2011 0.87
50 Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand 2014 0.87
51 What really matters to bipolar patients' caregivers: sources of family burden. J Affect Disord 2006 0.86
52 Treatment of refractory rapid cycling bipolar disorder with risperidone. J Clin Psychopharmacol 1998 0.86
53 Antidepressant-induced mania in obsessive-compulsive disorder. Am J Psychiatry 1992 0.85
54 A bibliometric study of the use of the classification and diagnostic systems in psychiatry over the last 25 years. Psychopathology 2008 0.85
55 Treatment adherence in bipolar I and schizoaffective disorder, bipolar type. J Affect Disord 2013 0.85
56 Neurocognitive impairment across the bipolar spectrum. CNS Neurosci Ther 2011 0.85
57 Cognitive impairment in schizoaffective disorder: a comparison with non-psychotic bipolar and healthy subjects. Acta Psychiatr Scand 2007 0.85
58 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery. Eur Neuropsychopharmacol 2010 0.84
59 Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology. Acta Psychiatr Scand 2009 0.84
60 Clinical and prognostic implications of seasonal pattern in bipolar disorder: a 10-year follow-up of 302 patients. Psychol Med 2007 0.84
61 The impact of repeated manic episodes and executive dysfunction on work adjustment in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2013 0.84
62 Depression subtypes in bipolar I and II disorders. Psychopathology 2007 0.84
63 Neuropsychological performance in depressed and euthymic bipolar patients. Neuropsychobiology 2002 0.83
64 Patterns of drug treatment for manic episode in the clinical practice. Outcomes of the Spanish sample in the EMBLEM Study. Actas Esp Psiquiatr 2007 0.83
65 Brain functional abnormality in schizo-affective disorder: an fMRI study. Psychol Med 2012 0.83
66 In-patient care costs of patients with bipolar I disorder: a comparison between two European centers. J Affect Disord 2009 0.83
67 The CACNA1C risk allele selectively impacts on executive function in bipolar type I disorder. Acta Psychiatr Scand 2013 0.82
68 Neurocognitive impairment and psychosocial functioning in bipolar II disorder. Acta Psychiatr Scand 2011 0.82
69 Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder. Bipolar Disord 2008 0.82
70 Atypical depression is associated with suicide attempt in bipolar disorder. Acta Psychiatr Scand 2009 0.81
71 Subthreshold symptoms and time to relapse/recurrence in a community cohort of bipolar disorder outpatients. J Affect Disord 2012 0.81
72 Functioning and symptomatic outcomes in patients with bipolar I disorder in syndromal remission: a 1-year, prospective, observational cohort study. J Affect Disord 2010 0.81
73 What is the role of psychotherapy in the treatment of bipolar disorder? Psychother Psychosom 1998 0.81
74 Rates and clinical correlates of treatment non-adherence in schizoaffective bipolar patients. Acta Psychiatr Scand 2012 0.81
75 Genetic variability at IMPA2, INPP1 and GSK3β increases the risk of suicidal behavior in bipolar patients. Eur Neuropsychopharmacol 2013 0.80
76 What we know and what we don't know about the treatment of schizoaffective disorder. Eur Neuropsychopharmacol 2011 0.80
77 Neuropsychological profile in bipolar disorder: a preliminary study of monotherapy lithium-treated euthymic bipolar patients evaluated at a 2-year interval. Acta Psychiatr Scand 2008 0.80
78 Efficacy and safety of two treatment algorithms in bipolar depression consisting of a combination of lithium, lamotrigine or placebo and paroxetine. Acta Psychiatr Scand 2010 0.79
79 Parents with bipolar disorder: are disease characteristics good predictors of psychopathology in offspring? Eur Psychiatry 2012 0.79
80 Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls. Psychol Med 2012 0.79
81 Process of adaptation to Spanish of the Temperament Evaluation of Memphis, Pisa, Paris and San Diego Scale. Self applied version (TEMPS-A). Actas Esp Psiquiatr 2005 0.79
82 The somatics of psyche: structural neuromorphometry of bipolar disorder. Psychother Psychosom 2002 0.79
83 Bipolar disorder in the elderly: a cohort study comparing older and younger patients. Acta Psychiatr Scand 2014 0.79
84 [Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder]. Actas Esp Psiquiatr 2009 0.79
85 Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials. CNS Neurosci Ther 2009 0.78
86 Reboxetine-induced hypomania. J Clin Psychiatry 2001 0.78
87 Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial. Acta Psychiatr Scand 2013 0.78
88 Clinical factors leading to lamotrigine prescription in bipolar outpatients: subanalysis of the SIN-DEPRES study. J Affect Disord 2012 0.78
89 Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain: a preliminary study. Neuroscience 2006 0.78
90 Therapeutic interventions focused on the family of bipolar patients. Psychother Psychosom 2001 0.77
91 Factors associated with initial treatment response with antidepressants in bipolar disorder. Eur Neuropsychopharmacol 2010 0.77
92 [Psychiatric morbidity in elderly patients admitted to a general hospital. A day-prevalence study]. Med Clin (Barc) 1991 0.77
93 Screening for bipolar disorder in a Spanish sample of outpatients with current major depressive episode. J Affect Disord 2008 0.77
94 Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. J Affect Disord 2012 0.77
95 Recall and recognition confabulation in psychotic and bipolar disorders: evidence for two different types without unitary mechanisms. Compr Psychiatry 2004 0.76
96 When should mood stabilizers be withdrawn due to lack of efficacy? Some methodological considerations. Eur Psychiatry 2011 0.76
97 Occupational disability in bipolar disorder: analysis of predictors of being on severe disablement benefit (PREBIS study data). Acta Psychiatr Scand 2012 0.76
98 Faster onset of antimanic action with haloperidol compared to second-generation antipsychotics. A meta-analysis of randomized clinical trials in acute mania. Eur Neuropsychopharmacol 2012 0.76
99 Work impairment in bipolar disorder patients--results from a two-year observational study (EMBLEM). Eur Psychiatry 2010 0.75
100 [Long-term effects of the treatment with risperidone versus conventional neuroleptics on the neuropsychological performance of euthymic bipolar patients]. Actas Esp Psiquiatr 2000 0.75
101 [Characteristics of psychiatric patients seeking medical advice]. Med Clin (Barc) 1998 0.75
102 [Tools to measure quality of life in Spain]. Med Clin (Barc) 1994 0.75
103 Suicide risk in schizophrenia. Am J Psychiatry 1998 0.75
104 [Burdened women: the differential diagnosis and treatment]. Med Clin (Barc) 1995 0.75
105 [Why do research?]. Med Clin (Barc) 1998 0.75
106 [Bipolar disorder, cognitive functioning and hypothalamic-pituitary-thyroid axis]. Actas Esp Psiquiatr 2010 0.75
107 Mannitol-induced acute manic state. J Clin Psychiatry 2001 0.75
108 Topiramate abuse in a bipolar patient with an eating disorder. J Clin Psychiatry 2001 0.75
109 [Somatization disorder in primary health care]. Med Clin (Barc) 1996 0.75
110 Syndromal and subsyndromal illness status and five-year morbidity using criteria of the International Society for Bipolar Disorders compared to alternative criteria. Psychopathology 2012 0.75
111 Treatment of mixed mania with risperidone and mood stabilizers. Can J Psychiatry 2001 0.75
112 Suicide attempts of high medical seriousness in schizophrenic patients. Compr Psychiatry 1993 0.75
113 Postpartum bipolar episodes are not distinct from spontaneous episodes: implications for DSM-V. J Affect Disord 2010 0.75
114 [Electroconvulsive therapy in the treatment of bipolar depression]. Actas Esp Psiquiatr 2007 0.75
115 [Spanish adaptation of the Seasonal Pattern Assessment Questionnaire (SPAQ) in the adult and children-adolescent versions]. Actas Esp Psiquiatr 2003 0.75
116 [An unusual case of confusional syndrome caused by corticoids]. Med Clin (Barc) 1990 0.75
117 Alpha-1-acid glycoprotein in major depressive disorder. Relationships to severity, response to treatment and imipramine plasma levels. J Affect Disord 2000 0.75
118 [Psychiatric investigation in Spain: shine and shade]. Med Clin (Barc) 1999 0.75
119 [A manic episode in a female patient with obsessive-compulsive disorder treated with chlorimipramine]. Med Clin (Barc) 1989 0.75
120 Serious suicide attempts in the elderly. Psychopathology 1992 0.75
121 [Suicide mortality in Olot from 1936 until 2000]. Actas Esp Psiquiatr 2009 0.75
122 [Functional neuroimaging of emotions and bipolar disorder]. Actas Esp Psiquiatr 2000 0.75
123 Anxiety as a marker of severity in acute mania. Acta Psychiatr Scand 2012 0.75
124 [Barcelona Bipolar Eating Disorder Scale (BEDS): a self-administered scale for eating disturbances in bipolar patients]. Actas Esp Psiquiatr 2004 0.75
125 [Rapid cycling following the administration of corticoids to a patient with bipolar disorder]. Med Clin (Barc) 1995 0.75
126 [Functional neuroimaging in patients with rapid cycling bipolar depression]. Rev Esp Med Nucl 2001 0.75
127 [Suicide attempts in patients with organic disease]. Med Clin (Barc) 1992 0.75
128 [The bipolar disease]. Med Clin (Barc) 1995 0.75